HCA Healthcare Inc

HCA: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|sYLOCK|<BgrqLOCK|&wNkn%R

HCA Earnings: Benefits From Elevated Medical Utilization Boost 2025 Guidance

HCA turned in 6% revenue growth in the quarter, and including margin expansion and share repurchases, adjusted EPS grew 24% year over year. On these results, management raised its guidance for 2025, including adjusted EPS of $25.50-$27.00, up from $24.05-$25.85 previously.

Sponsor Center